L3 Skeletal Muscle Index on Preoperative Computed Tomography and Its Association with Clinical Outcomes in Patients with Colorectal Cancer

Authors

  • Sarin Visase Department of Radiology, Sing Buri Hospital, Sing Buri.

Keywords:

CT-defined sarcopenia, L3 skeletal muscle index, Colorectal cancer, Postoperative complications, Dual-energy computed tomography

Abstract

This retrospective prognostic study evaluated the prevalence of CT-defined sarcopenia and its association with postoperative outcomes in 170 colorectal cancer (CRC) patients undergoing surgical resection at Singburi Hospital during 2020-2024. Sarcopenia was assessed using the L3 skeletal muscle index (L3 SMI), which was measured from preoperative CT images using semi-automated segmentation. Sex-specific thresholds were applied: ≤38.89 cm²/m² for males and ≤33.28 cm²/m² for females. Outcomes included postoperative complications graded by the Clavien-Dindo classification, length of hospital stay (LOS), overall survival (OS), and disease-free survival (DFS). Survival was analyzed using the restricted mean survival time (RMST) at 60 months.

The results showed that the mean age was 66.6 ± 10.5 years, and 52.4% of patients were male. CT-defined sarcopenia was identified in 32.4% of the patients, with excellent intra-rater reliability (ICC = 0.984). Sarcopenic patients had significantly higher rates of Clavien-Dindo grade ≥2 (OR 2.53, 95% CI 1.26-5.08; p = 0.008) and grade ≥3 (OR 2.22, 95% CI 1.10-4.48; p = 0.024) complications. LOS and RMST for OS and DFS did not differ significantly between groups. BMI was the only baseline variable that differed significantly (19.6 ± 3.1 vs. 23.9 ± 4.6 kg/m²; p < 0.001).

In conclusion, CT-defined sarcopenia affects approximately one-third of Thai CRC patients and is associated with increased postoperative morbidity. L3 SMI measurement derived from routinely acquired preoperative CT may provide supplementary information for surgical risk assessment when considered alongside other clinical factors. Further validation is required before routine clinical use.

Downloads

Download data is not yet available.

Author Biography

Sarin Visase, Department of Radiology, Sing Buri Hospital, Sing Buri.

Medical Physician, Professional Level.

References

Virani S, Bilheem S, Chansaard W, Chitapanarux I, Daoprasert K, Khuanchana S, et al. National and subnational population-based incidence of cancer in Thailand: Assessing cancers with the highest burdens. Cancers (Basel). 2017;9(8):108. https://doi.org/10.3390/cancers9080108

Vergara-Fernandez O, Trejo-Avila M, Salgado-Nesme N. Sarcopenia in patients with colorectal cancer: A comprehensive review. World J Clin Cases. 2020;8 (7):1188–202. https://doi.org/10.12998/wjcc.v8.i7.1188

Keshavjee S, Mckechnie T, Shi V, Abbas M, Huang E, Amin N, et al. The impact of sarcopenia on postoperative outcomes in colorectal cancer surgery: An updated systematic review and meta-analysis. Am Surg. 2025;91(5):887–900. https://doi.org/10.1177/00031348251329748

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1) :16–31. https://doi.org/10.1093/ageing/afy169

Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G, et al. The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep. 2020;10(1):8153. https://doi.org/10.1038/s41598-020-65091-0

Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13. https://doi.org/10.1097/01.sla.0000133083.54934.ae

Royston P, Parmar MKB. The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt. Stat Med. 2011;30(19):2409–21. https://doi.org/10.1002/sim.4274

Royston P, Parmar MKB. Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome. BMC Med Res Methodol. 2013;13(1):152. https://doi.org/10.1186/1471-2288-13-152

He J, Luo W, Huang Y, Song L, Mei Y. Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis. Front Oncol. 2023;13:1247341. https://doi.org/10.3389/fonc.2023.1247341

Beaumont H, Khayat E, Thinnes A, Iannessi A. Technical performance of L3 skeletal muscle area (SMA) measurement on CT for L3 skeletal muscle index (L3SMI) assessment. Sci Rep. 2026;16(1):21590. https://doi.org/10.1038/s41598-026-51010-2

Nagarajan G, Doshi P, Bardeskar NS, Kulkarni A, Punamiya A, Tongaonkar H. Association between sarcopenia and postoperative complications in patients undergoing surgery for gastrointestinal or hepato-pancreatico-biliary cancer. J Surg Oncol. 2023;128(4):682–91. https://doi.org/10.1002/jso.27315

Traeger L, Bedrikovetski S, Nguyen TM, Kwan YX, Lewis M, Moore JW, et al. The impact of preoperative sarcopenia on postoperative ileus following colorectal cancer surgery. Tech Coloproctol. 2023;27(12):1265–74. https://doi.org/10.1007/s10151-023-02812-3

Lin W-L, Nguyen T-H-Y, Huang W-T, Guo H-R, Wu L-M. Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2024;39(11):2250–9. https://doi.org/10.1111/jgh.16681

Zhang L, Guan J, Ding C, Feng M, Gong L, Guan W. Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer. Front Nutr. 2022;9:1047029. https://doi.org/10.3389/fnut.2022.1047029

Graffy PM, Liu J, Pickhardt PJ, Burns JE, Yao J, Summers RM. Deep learning-based muscle segmentation and quantification at abdominal CT: application to a longitudinal adult screening cohort for sarcopenia assessment. Br J Radiol. 2019;92(1100):20190327. https://doi.org/10.1259/bjr.20190327

Downloads

Published

16-10-2026

How to Cite

1.
Visase S. L3 Skeletal Muscle Index on Preoperative Computed Tomography and Its Association with Clinical Outcomes in Patients with Colorectal Cancer . Singburi Hosp J [internet]. 2026 Oct. 16 [cited 2026 Oct. 18];35(3):B1-B11. available from: https://he01.tci-thaijo.org/index.php/shj/article/view/289858